Tarava’s story illustrates the remarkable progress Zimbabwe has made in tackling the HIV crisis. Once ravaged by soaring ...
Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a year and has demonstrated over 99.9% effectiveness in preventing HIV ...
New study findings could change treatments for HIV in young children. HIV remission may be possible for very young children ...
This antiretroviral has shown unprecedented results in HIV prevention, requiring only two injections per year. Its ...
AllAfrica on MSN
Bulawayo HIV Burden Eases - New Infections Drop 44%
The number of people living with HIV in Bulawayo has declined from 79 711 in 2020 to 76 608 in 2024, as new infections continue to fall in response to significant progress in prevention and treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback